Evaluation of the efficacy and safety of paliperidone extended-release in the treatment of acute mania: A randomized, double-blind, dose-response study
Data up to Jan 2025
Total Citations Per Year
Abstract
References (32)
The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia
1987 • 19,723 citations
A New Depression Scale Designed to be Sensitive to Change
1979 • 12,729 citations
A Rating Scale for Mania: Reliability, Validity and Sensitivity
1978 • 8,000 citations
Bipolar Disorder
2011 • 3,572 citations
A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS
1970 • 3,213 citations
Assessment of suicidal intention: The Scale for Suicide Ideation.
1979 • 2,485 citations
Assessment of suicidal intention: The Scale for Suicide Ideation.
1979 • 2,374 citations
Cross-National Epidemiology of Major Depression and Bipolar Disorder
1996 • 2,176 citations
A Rating Scale for Drug-Induced Akathisia
1989 • 2,135 citations
Modification of the Clinical Global Impressions (CGI) scale for use in bipolar illness (BP): the CGI-BP
1997 • 942 citations
Olanzapine versus Placebo and Haloperidol
1996 • 788 citations
Multiple fixed doses of “Seroquel” (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placebo
1997 • 756 citations
Risperidone in the Treatment of Patients with Chronic Schizophrenia: a Multi-National, Multi-Centre, Double-Blind, Parallel-Group Study versus Haloperidol
1995 • 558 citations
Treatment of schizophrenia with paliperidone extended-release tablets: A 6-week placebo-controlled trial☆
2006 • 282 citations
Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double‐blind, placebo‐controlled study
2004 • 267 citations
Mood stabilisers plus risperidone or placebo in the treatment of acute mania
2003 • 258 citations
Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER): Results of a 6-week, randomized, placebo-controlled study
2007 • 240 citations
Efficacy and Safety of Paliperidone Extended-Release Tablets: Results of a 6-Week, Randomized, Placebo-Controlled Study
2007 • 218 citations
Atypical Antipsychotics in the Treatment of Mania
2006 • 199 citations
Risperidone in the treatment of acute mania
2005 • 189 citations
Frequency of Positive Studies Among Fixed and Flexible Dose Antidepressant Clinical Trials: An Analysis of the Food and Drug Administraton Summary Basis of Approval Reports
2002 • 160 citations
A randomized, placebo‐ and active‐controlled study of paliperidone extended release for the treatment of acute manic and mixed episodes of bipolar I disorder
2010 • 107 citations
Research Design Features and Patient Characteristics Associated With the Outcome of Antidepressant Clinical Trials
2004 • 94 citations
Atypical antipsychotics in bipolar disorder: systematic review of randomised trials
2007 • 92 citations
A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania
2007 • 74 citations
Evaluating dose response from flexible dose clinical trials
2008 • 37 citations
Dose trends for second-generation antipsychotic treatment of schizophrenia and bipolar disorder
2008 • 33 citations
Treatment of bipolar disorder: the evolving role of atypical antipsychotics.
2007 • 26 citations
P.2.150 Ziprasidone in adjunctive treatment of acute bipolar mania: A randomized, double-blind placebo-controlled trial
2003 • 23 citations
Quetiapine in the treatment of acute mania: Target dose for efficacious treatment
2007 • 19 citations
A Dunnett–Bonferroni‐based parallel gatekeeping procedure for dose–response clinical trials with multiple endpoints
2008 • 16 citations
Typical neuroleptics vs. atypical antipsychotics in the treatment of acute mania in a natural setting
2005 • 6 citations